{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T22:36:15Z","timestamp":1778193375789,"version":"3.51.4"},"reference-count":26,"publisher":"BMJ","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Neurology, Neurosurgery & Psychiatry"],"published-print":{"date-parts":[[1975,3,1]]},"DOI":"10.1136\/jnnp.38.3.225","type":"journal-article","created":{"date-parts":[[2008,11,10]],"date-time":"2008-11-10T21:02:42Z","timestamp":1226350962000},"page":"225-231","source":"Crossref","is-referenced-by-count":47,"title":["Involuntary movements caused by phenytoin intoxication in epileptic patients."],"prefix":"10.1136","volume":"38","author":[{"given":"S","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Laidlaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G W","family":"Houghton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Richens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/cpt1970111121","article-title":"The rate of decline of diphenylhydantoin in human plasma","volume":"11","author":"Arnold, K.; Gerber, N.","year":"1970","unstructured":"Arnold, K., and Gerber, N. (1970). The rate of decline of diphenylhydantoin in human plasma. Clinical Pharmacology and Therapeutics, 11, 121-134.","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/cpt1973144part1521","article-title":"Pharmacokinetic study of a patient with diphenylhydantoin toxicity","volume":"14","author":"Atkinson, Jr, A.J.; Shaw, J.M.","year":"1973","unstructured":"Atkinson, A. J., Jr, and Shaw, J. M. (1973). Pharmacokinetic study of a patient with diphenylhydantoin toxicity. Clinical Pharmacology and Therapeutics, 14, 521-528.","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1136\/jnnp.35.6.873","article-title":"Effect of dosage increments on blood phenytoin concentrations","volume":"35","author":"Bochner, F.; Hooper, W.D.; Tyrer, J.H.; Eadie, M.J.","year":"1972","unstructured":"Bochner, F., Hooper, W. D., Tyrer, J. H., and Eadie, M. J. (1972). Effect of dosage increments on blood phenytoin concentrations. Journal of Neurology, Neurosurgery, and Psychiatry, 35, 873-876.","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"ref_4","first-page":"227","volume-title":"Diphenylhydantoin. Neurologic aspects of toxicity. In Antiepileptic Drugs","author":"Dam, M.","year":"1972","unstructured":"Dam, M. (1972). Diphenylhydantoin. Neurologic aspects of toxicity. In Antiepileptic Drugs, pp. 227-235. Edited by D. M. Woodbury, J. K. Penry, and R. P. Schmidt. Raven Press: New York."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0140-6736(71)92787-5","volume":"2","author":"Engel, J.; Cruz, M.E.; Shapiro, B.","year":"1971","unstructured":"Engel, J., Cruz, M. E., and Shapiro, B. (1971). Phenytoin encephalopathy? Lancet, 2, 824-825.","journal-title":"Phenytoin encephalopathy? Lancet"},{"key":"ref_6","first-page":"455","article-title":"Explanation of dosedependent decline of diphenylhydantoin plasma levels by fitting to the integrated form of the Michaelis-Menten equation","volume":"3","author":"Gerber, N.; Wagner, J.G.","year":"1972","unstructured":"Gerber, N., and Wagner, J. G. (1972). Explanation of dosedependent decline of diphenylhydantoin plasma levels by fitting to the integrated form of the Michaelis-Menten equation. Research Communications in Chemical Pathology and Pharmacology, 3, 455-466.","journal-title":"Research Communications in Chemical Pathology and Pharmacology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/bmj.1.5689.147","article-title":"Supervision of epileptic patients taking phenytoin","volume":"1","author":"Gibberd, F.B.; Dunne, J.F.; Handley, A.J.; Hazleman, B.L.","year":"1970","unstructured":"Gibberd, F. B., Dunne, J. F., Handley, A. J., and Hazleman, B. L. (1970). Supervision of epileptic patients taking phenytoin. British Medical Journal, 1, 147-149.","journal-title":"British Medical Journal"},{"key":"ref_8","first-page":"219","article-title":"Diphenylhydantoin. Toxicity","volume-title":"Antiepileptic Drugs","author":"Glaser, G.H.","year":"1972","unstructured":"Glaser, G. H. (1972). Diphenylhydantoin. Toxicity. In Antiepileptic Drugs, pp. 219-226. Edited by D. M. Woodbury, J. K. Penry, and R. P. Schmidt. Raven Press: New York."},{"key":"ref_9","author":"Gruber, C.M.; Haury, V.G.; Drake, M.E.","year":"1940","unstructured":"Gruber, C. M., Haury, V. G., and Drake, M. E. (1940)."},{"key":"ref_10","first-page":"\"433","article-title":"The toxic actions of sodium diphenyl hydantoinate (Dilantin) when injected intraperitoneally and intravenously in experimental animals","volume":"68","author":"Hansen, J.M.; Kristensen, M.; Skovsted, L.","year":"1968","unstructured":"The toxic actions of sodium diphenyl hydantoinate (Dilantin) when injected intraperitoneally and intravenously in experimental animals. Journal of Pharmacology and Experimental Therapeutics, 68, 433-436. Hansen, J. M., Kristensen, M., and Skovsted, L. (1968). Sulthiame (Ospolot) as inhibitor of diphenylhydantoin metabolism. Epilepsia, 9, 17-22.","journal-title":"Journal of Pharmacology and Experimental Therapeutics; Sulthiame (Ospolot) as inhibitor of diphenylhydantoin metabolism"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/jnnp.37.3.275","article-title":"Phenytoin intoxication induced by sulthiame in epileptic patients","volume":"37","author":"Houghton, G.W.; Richens, A.","year":"1974","unstructured":"Houghton, G. W., and Richens, A. (1974a). Phenytoin intoxication induced by sulthiame in epileptic patients. Journal of Neurology, Neurosurgery, and Psychiatry, 37, 275-281.","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2125.1974.tb00207.x","article-title":"Inhibition of phenytoin metabolism by sulthiame in epileptic patients","volume":"1","author":"Houghton, G.W.; Richens, A.","year":"1974","unstructured":"Houghton, G. W., and Richens, A. (1974b). Inhibition of phenytoin metabolism by sulthiame in epileptic patients. British Journal of Clinical Pharmacology, 1, 59-66.","journal-title":"British Journal of Clinical Pharmacology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2125.1974.tb00225.x","article-title":"Rate of elimination of tracer doses of phenytoin at different steady-state serum phenytoin concentrations in epileptic patients","volume":"1","author":"Houghton, G.W.; Richens, A.","year":"1974","unstructured":"Houghton, G. W., and Richens, A. (1974c). Rate of elimination of tracer doses of phenytoin at different steady-state serum phenytoin concentrations in epileptic patients. British Journal of Clinical Pharmacology, 1, 155-161.","journal-title":"British Journal of Clinical Pharmacology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1528-1157.1970.tb03882.x","article-title":"Influence of ethylphenacemide on serum levels of other anti-epileptic drugs","volume":"11","author":"Huisman, J.W.; Heycop Ten Ham, M.W.van; Zijl, C.H.W.van","year":"1970","unstructured":"Huisman, J. W., Heycop Ten Ham, M. W. van, and Zijl, C. H. W. van (1970). Influence of ethylphenacemide on serum levels of other anti-epileptic drugs. Epilepsia, 11, 207-215.","journal-title":"Epilepsia"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1212\/WNL.24.1.68","article-title":"Movement disorder as a manifestation of diphenylhydantoin intoxication","volume":"24","author":"Kooiker, J.C.; Sumi, S.M.","year":"1974","unstructured":"Kooiker, J. C., and Sumi, S. M. (1974). Movement disorder as a manifestation of diphenylhydantoin intoxication. Neurology (Minneap.), 24, 68-71.","journal-title":"Neurology (Minneap.)"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1212\/WNL.16.6.594","article-title":"Depression of parahydroxylation of diphenylhydantoin by antituberculosis chemotherapy","volume":"16","author":"Kutt, H.; Winters, W.; McDowell, F.H.","year":"1966","unstructured":"Kutt, H., Winters, W., and McDowell, F. H. (1966). Depression of parahydroxylation of diphenylhydantoin by antituberculosis chemotherapy. Neurology (Minneap.), 16, 594-602.","journal-title":"Neurology (Minneap.)"},{"key":"ref_17","first-page":"169","article-title":"Diphenylhydantoin. Interactions with other drugs","volume-title":"man. In Antiepileptic Drugs","author":"Kutt, H.","year":"1972","unstructured":"Kutt, H. (1972). Diphenylhydantoin. Interactions with other drugs in man. In Antiepileptic Drugs, pp. 169-180. Edited by D. M. Woodbury, J. K. Penry, and R. P. Schmidt. Raven Press: New York."},{"key":"ref_18","first-page":"716","article-title":"Diphenylhydantoin activated seizures","volume":"15","author":"Levy, L.L.; Fenichel, G.M.","year":"1965","unstructured":"Levy, L. L., and Fenichel, G. M. (1965). Diphenylhydantoin activated seizures. Neurology (Minneap.), 15, 716-722.","journal-title":"Neurology (Minneap.)"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/archneur.1969.00480180087008","article-title":"Pseudodegenerative disease due to diphenylhydantoin intoxication","volume":"21","author":"Logan, W.J.; Freeman, J.M.","year":"1969","unstructured":"Logan, W. J., and Freeman, J. M. (1969). Pseudodegenerative disease due to diphenylhydantoin intoxication. Archives of Neurology, 21, 631-637.","journal-title":"Archives of Neurology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/bmj.2.5912.204","article-title":"Choreo-athetosis and encephalopathy induced by phenytoin","volume":"2","author":"McLellan, D.L.; Swash, M.","year":"1974","unstructured":"McLellan, D. L., and Swash, M. (1974). Choreo-athetosis and encephalopathy induced by phenytoin. British Medical Journal, 2, 204-205.","journal-title":"British Medical Journal"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1365-2125.1974.tb00226.x","article-title":"Phenytoin dose adjustment in epileptic patients","volume":"1","author":"Mawer, G.E.; Mullen, P.W.; Rodgers, M.; Robins, A.J.; Lucas, S.B.","year":"1974","unstructured":"Mawer, G. E., Mullen, P. W., Rodgers, M., Robins, A. J., and Lucas, S. B. (1974). Phenytoin dose adjustment in epileptic patients. British Journal of Clinical Pharmacology, 1, 163-168.","journal-title":"British Journal of Clinical Pharmacology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1136\/bmj.2.5008.1529","article-title":"Rare complication of phenytoin sodium treatment","volume":"2","author":"Morris, J.V.; Fischer, E.; Bergin, J.T.","year":"1956","unstructured":"Morris, J. V., Fischer, E., and Bergin, J. T. (1956). Rare complication of phenytoin sodium treatment. British Medical Journal, 2, 1529.","journal-title":"British Medical Journal"},{"key":"ref_23","first-page":"589","article-title":"Unrecognized dilantin intoxication","volume-title":"Modern Neurology","author":"Perlo, V.P.; Schwab, R.S.","year":"1969","unstructured":"Perlo, V. P., and Schwab, R. S. (1969). Unrecognized dilantin intoxication. In Modern Neurology, pp. 589-597. Edited by S. Locke. Little, Brown: Boston."},{"key":"ref_24","first-page":"299","article-title":"Anticonvulsant drug intolerance","volume":"12","author":"Peters, H.A.","year":"1962","unstructured":"Peters, H. A. (1962). Anticonvulsant drug intolerance. Neurology (Minneap.), 12, 299.","journal-title":"Neurology (Minneap.)"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1177\/003591577406712P115","article-title":"Drug estimation in the treatment of epilepsy","volume":"67","author":"Richens, A.","year":"1974","unstructured":"Richens, A. (1974). Drug estimation in the treatment of epilepsy. Proceedings of the Royal Society of Medicine, 67, 1227-1229.","journal-title":"Proceedings of the Royal Society of Medicine"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"912921","DOI":"10.1212\/WNL.11.10.912","article-title":"Dilantin toxicity. A clinical and electroencephalographic study","volume":"11","author":"Roseman, E.","year":"1961","unstructured":"Roseman, E. (1961). Dilantin toxicity. A clinical and electroencephalographic study. Neurology (Minneap.), 11, 912921.","journal-title":"Neurology (Minneap.)"}],"container-title":["Journal of Neurology, Neurosurgery & Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp.38.3.225","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T02:32:09Z","timestamp":1601087529000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp.38.3.225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1975,3,1]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1975,3,1]]}},"URL":"https:\/\/doi.org\/10.1136\/jnnp.38.3.225","relation":{},"ISSN":["0022-3050"],"issn-type":[{"value":"0022-3050","type":"print"}],"subject":[],"published":{"date-parts":[[1975,3,1]]}}}